(ADM) Archer-Daniels-Midland - Overview
Sector: Consumer Defensive | Industry: Farm Products | Exchange: NYSE (USA) | Market Cap: 38.450m USD | Total Return: 82% in 12m
Avg Turnover: 289M
EPS Trend: -98.6%
Qual. Beats: 0
Rev. Trend: -97.7%
Qual. Beats: -2
Warnings
No concerns identified
Tailwinds
Rs Leader, Idiosyncratic Leader, Tailwind, Confidence
Archer-Daniels-Midland Company (ADM) is a global leader in agricultural processing and nutrition, operating an extensive network for the origination, transportation, and storage of raw materials. The companys business model is integrated across three primary segments: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. By converting crops like soybeans, corn, and wheat into ingredients for food, animal feed, and industrial energy, ADM occupies a critical position in the global food supply chain.
The company operates within the Agricultural Products & Services sector, which is characterized by high capital intensity and sensitivity to global commodity price fluctuations. ADM differentiates itself through a diversified portfolio that includes specialty ingredients such as probiotics, plant-based proteins, and enzymes, alongside traditional bulk commodities. This diversification helps mitigate the cyclical nature of raw agricultural markets by capturing higher-margin value in the human and animal nutrition spaces.
Further analysis of ADM’s financial health and valuation trends is available on ValueRay. Founded in 1902 and headquartered in Chicago, the company also maintains specialized operations in structured trade finance, carbon sequestration, and insurance to support its global logistics and processing footprint.
- Global soybean crush margins and agricultural commodity price volatility impact processing profitability
- Biofuel demand and government mandates drive vegetable oil and ethanol revenue growth
- Expansion of high-margin nutrition segment reduces dependence on cyclical commodity trading volumes
- Regulatory investigations into intersegment accounting practices influence investor confidence and valuation
| Net Income: 1.08b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 8.20 > 1.0 |
| NWC/Revenue: 8.83% < 20% (prev 9.20%; Δ -0.37% < -1%) |
| CFO/TA 0.11 > 3% & CFO 5.94b > Net Income 1.08b |
| Net Debt (11.4b) to EBITDA (2.41b): 4.71 < 3 |
| Current Ratio: 1.31 > 1.5 & < 3 |
| Outstanding Shares: last quarter (484.0m) vs 12m ago 0.21% < -2% |
| Gross Margin: 5.83% > 18% (prev 6.32%; Δ -0.49% > 0.5%) |
| Asset Turnover: 147.9% > 50% (prev 157.0%; Δ -9.13% > 0%) |
| Interest Coverage Ratio: 2.15 > 6 (EBIT TTM 1.23b / Interest Expense TTM 571.0m) |
| A: 0.13 (Total Current Assets 30.0b - Total Current Liabilities 22.9b) / Total Assets 55.6b |
| B: 0.40 (Retained Earnings 22.0b / Total Assets 55.6b) |
| C: 0.02 (EBIT TTM 1.23b / Avg Total Assets 54.5b) |
| D: 0.70 (Book Value of Equity 22.8b / Total Liabilities 32.5b) |
| Altman-Z'' = 3.02 = A |
| DSRI: 0.90 (Receivables 5.68b/6.58b, Revenue 80.6b/83.9b) |
| GMI: 1.08 (GM 6.32% / 5.83%) |
| AQI: 0.97 (AQ_t 0.24 / AQ_t-1 0.25) |
| SGI: 0.96 (Revenue 80.6b / 83.9b) |
| TATA: -0.09 (NI 1.08b - CFO 5.94b) / TA 55.6b) |
| Beneish M = -3.09 (Cap -4..+1) = AA |
As of June 05, 2026, the stock is trading at USD 83.37 with a total of 2,448,937 shares traded.
Over the past week, the price has changed by +4.16%,
over one month by +10.03%,
over three months by +24.84% and
over the past year by +82.04%.
Archer-Daniels-Midland has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold ADM.
- StrongBuy: 1
- Buy: 0
- Hold: 9
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 74.1 | -11.1% |
P/E Trailing = 35.6161
P/E Forward = 17.331
P/S = 0.4771
P/B = 1.6861
P/EG = 2.5255
Revenue TTM = 80.6b USD
EBIT TTM = 1.23b USD
EBITDA TTM = 2.41b USD
Long Term Debt = 6.46b USD (from longTermDebt, last quarter)
Short Term Debt = 3.17b USD (from shortTermDebt, last quarter)
Debt = 12.0b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.33b
Net Debt = 11.4b USD (calculated: Debt 12.0b - CCE 624.0m)
Enterprise Value = 49.8b USD (38.5b + Debt 12.0b - CCE 624.0m)
Interest Coverage Ratio = 2.15 (Ebit TTM 1.23b / Interest Expense TTM 571.0m)
EV/FCF = 10.39x (Enterprise Value 49.8b / FCF TTM 4.79b)
FCF Yield = 9.62% (FCF TTM 4.79b / Enterprise Value 49.8b)
FCF Margin = 5.95% (FCF TTM 4.79b / Revenue TTM 80.6b)
Net Margin = 1.34% (Net Income TTM 1.08b / Revenue TTM 80.6b)
Gross Margin = 5.83% ((Revenue TTM 80.6b - Cost of Revenue TTM 75.9b) / Revenue TTM)
Gross Margin QoQ = 5.96% (prev 6.54%)
Tobins Q-Ratio = 0.90 (Enterprise Value 49.8b / Total Assets 55.6b)
Interest Expense / Debt = 4.76% (Interest Expense 571.0m / Debt 12.0b)
Taxrate = 15.71% (202.0m / 1.29b)
NOPAT = 1.03b (EBIT 1.23b * (1 - 15.71%))
Current Ratio = 1.31 (Total Current Assets 30.0b / Total Current Liabilities 22.9b)
Debt / Equity = 0.53 (Debt 12.0b / totalStockholderEquity, last quarter 22.8b)
Debt / EBITDA = 4.71 (Net Debt 11.4b / EBITDA 2.41b)
Debt / FCF = 2.37 (Net Debt 11.4b / FCF TTM 4.79b)
Total Stockholder Equity = 22.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.98% (Net Income 1.08b / Total Assets 55.6b)
RoE = 4.78% (Net Income TTM 1.08b / Total Stockholder Equity 22.6b)
RoCE = 4.21% (EBIT 1.23b / Capital Employed (Equity 22.6b + L.T.Debt 6.46b))
RoIC = 2.93% (NOPAT 1.03b / Invested Capital 35.3b)
WACC = 6.08% (E(38.5b)/V(50.4b) * Re(6.72%) + D(12.0b)/V(50.4b) * Rd(4.76%) * (1-Tc(0.16)))
Discount Rate = 6.72% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -46.56 | Cagr: -4.91%
[DCF] Terminal Value 77.97% ; FCFF base≈2.97b ; Y1≈3.40b ; Y5≈5.00b
[DCF] Fair Price = 132.6 (EV 75.3b - Net Debt 11.4b = Equity 63.9b / Shares 482.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -98.63 | EPS CAGR: -28.58% | SUE: 0.48 | # QB: 0
Revenue Correlation: -97.69 | Revenue CAGR: -7.53% | SUE: -1.00 | # QB: -2
EPS current Quarter (2026-06-30): EPS=1.41 | Chg30d=+40.49% | Revisions=+67% | Analysts=8
EPS next Quarter (2026-09-30): EPS=1.26 | Chg30d=+4.26% | Revisions=+33% | Analysts=8
EPS current Year (2026-12-31): EPS=4.69 | Chg30d=+11.89% | Revisions=+69% | GrowthEPS=+36.8% | GrowthRev=+6.8%
EPS next Year (2027-12-31): EPS=5.19 | Chg30d=+6.84% | Revisions=+54% | GrowthEPS=+10.6% | GrowthRev=+4.4%
[Analyst] Revisions Ratio: +69%